Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    CLCF1
Show Display Options
Rank Status Study
1 Unknown  Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Liuwei Dihuang Pills
2 Active, not recruiting CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome
Condition: Postmenopausal Osteoporosis
Intervention: Other: Liuwei Dihuang Pill
3 Unknown  Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: osteoporosis

Study has passed its completion date and status has not been verified in more than two years.